BJ
TCRT icon

BlackRock Japan’s Alaunos Therapeutics TCRT Stock Holding History

BlackRock Japan’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7K Hold
8
– – ﹤0.01% 1243
2016
Q3 		$7K Hold
8
– – ﹤0.01% 1238
2016
Q2 		$7K Hold
8
– – ﹤0.01% 1316
2016
Q1 		$9K Hold
8
– – ﹤0.01% 1301
2015
Q4 		$10K Buy
8
+4
+100% +$6.62K ﹤0.01% 1267
2015
Q3 		$5K Sell
4
-1
-20% -$1.65K ﹤0.01% 1215
2015
Q2 		$10K Buy
+5
New +$7.76K ﹤0.01% 1271

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Japan's TCRT Position: Q4 2016 in Review

BlackRock Japan held its Alaunos Therapeutics (TCRT) position steady in Q4 2016 at 8 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

BlackRock Japan first reported a position in TCRT in Q2 2015 and has held it in 7 quarters since. The position peaked at $10K in Q4 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • BlackRock Japan held 8 shares of Alaunos Therapeutics worth $7K as of Q4 2016.
  • BlackRock Japan left its Alaunos Therapeutics share count unchanged in Q4 2016.
  • Alaunos Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1243 holding.
  • BlackRock Japan first reported a position in Alaunos Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Japan's Alaunos Therapeutics position peaked at $10K in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.